Bionomics Signs Option and License Agreement With Merck

Bionomics Limited (OTC: BMICY ) today announced an agreement with Merck (NYSE: MRK ), known as MSD outside the United States and Canada, to discover and develop novel small molecule candidates for the treatment of chronic pain, including neuropathic pain. Under the terms of the agreement, Merck will have